CLINICAL CASE

PRESENTATION ON
STREPTOCOCCAL
TONSILLITIS
BY
OJOISIMI FRANCA JAMGBADI
Overview
• Streptococcal Tonsillitis also known as Strep throat,
Bacterial tonsillitis or Streptococcal pharyngitis.
• It is an infection of the back of the throat including
tonsils caused by group A streptococcus.
• Symptoms include fever, sore throat, red tonsils,
enlarged lymph nodes in the neck
Cont...
• A headache and nausea or vomiting may also occur.
Some develop a sandpaper-like rash which is known
as Scarlet fever.
• Symptoms usually occur one or three days after
exposure and last seven to ten days. Risk factors
include; sharing drinks or eating utensils.
Mode of Transmission
• Strep throat is spread by r
• espiratory droplets from an infected person. It may
be spread directly or by touching something that
has the droplets on it and then touching the mouth,
nose or eyes or through skin contact.
• Some people may carry the bacteria without
symptoms.
Diagnosis
• This is based on the results of a rapid antigen
detection test or throat culture in those who have
symptoms.
Treatment and Prognosis
• Antibiotics and pain medications.
• Symptoms usually improve within three to five days
irrespective of the treatment.
CASE PRESENTATION
Demographic data:
• Patient S.A is a 1year 8months old child and Bini by
tribe
FAMILY HISTORY
• Patient S.A is the first and only child of her parents.
SOCIAL HISTORY
• Both parents do not smoke nor take alcohol and no
previous history of such
PAST MEDICAL HISTORY
• Malaria
PAST MEDICAL HISTORY
• Malaria
PAST MEDICATION HISTORY
• Artesunate/Amodiaquine (Camosunate) and
Paracetamol
CHIEF COMPLAINT
• Elevated temperature, anorexia, cough, catarrh and
sneezing
DIAGNOSIS
• Streptococcal Tonsillitis
PLAN
• Azithromycin 5ml daily × 3/7

• Paracetamol 7.5ml tds × 3/7

EVALUATION OF DRUG
THERAPY
• AZITHROMYCIN: An antibiotic, belongs to the cbass
macrolides.
• It prevents bacteria from growing by interfering
with their protein synthesis.
• It binds to the 50s subunit of the bacteria
ribosome, thus inhibiting translation of mRNA.
Nucleic acid synthesis is not affected.
• Paracetamol: An analgesic with an unknown
mechanism of action.
DRUG THERAPY PROBLEMS
• Actual: Nil
• Potential: The type of drug therapy problem
identified is Adverse effect. Patient may experience
diarrhea or loose stools as well as abdominal pain
when taking Azithromycin.
GOALS PF THERAPY
• To alleviate patient's symptoms
• To improve patient's quality of life
PHARMACEUTICAL
INTERVENTIONS
• Drug Focused: Nil
• Patient Focused: Care giver counselled on how to
reconstitute Azithromycin as well as the
importanceof adherence.
DOCUMENTATION
• The pharmaceuticalcare plan was documented for
future purpose.
THANK YOU